Clinical Trial

Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to evaluate the effect of polymethylmethacrylate dialysis membranes use on the intensity of pruritus in patients with CKD stage 5D receiving maintenance hemodialysis. The main question it aims to answer is: Does the use of polymethylmethacrylate (PMMA) membranes reduce the intensity of pruritus in dialysis patients? Researchers will compare PMMA membranes to standard polysulfone-based membranes to see if PMMA works to reduce moderate-to-severe pruritis and pruritis-related quality of life. Participants will: * receive maintenance hemodialysis with PMMA or polysulfone membranes for 2 months; * fill in questionnaires about intensity of pruritis and its impact on daily life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-31.
Status change: Not Yet Recruiting → Recruiting 2025-03-02
Trial Details
NCT Number NCT06671535
Lead Sponsor Saint Petersburg State University, Russia
Conditions CKD (Chronic Kidney Disease) Stage 5D, Hemodialysis, Pruritis
Enrollment 62 participants
Start Date 2025-01-27
Primary Completion 2025-06 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-04